Annual ROE
-211.20%
+100.77%+32.30%
December 31, 2022
Summary
- As of February 10, 2025, ADMP annual return on equity is -211.20%, with the most recent change of +100.77% (+32.30%) on December 31, 2022.
- During the last 3 years, ADMP annual ROE has fallen by -142.15% (-205.87%).
Performance
ADMP ROE Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
High & Low
Earnings dates
Quarterly ROE
518.62%
+1337.89%+163.30%
June 30, 2023
Summary
- As of February 10, 2025, ADMP quarterly return on equity is 518.62%, with the most recent change of +1337.89% (+163.30%) on June 30, 2023.
- Over the past year, ADMP quarterly ROE has increased by +672.06% (+438.00%).
Performance
ADMP Quarterly ROE Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
High & Low
Earnings dates
ROE Formula
ROE = Net Income
Shareholders Equity ✕ 100%
Shareholders Equity ✕ 100%
ADMP ROE Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
|---|---|---|
| 1 y1 year | +32.3% | +438.0% |
| 3 y3 years | -205.9% | +645.8% |
| 5 y5 years | -168.1% | +675.7% |
ADMP ROE Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
|---|---|---|---|---|---|
| 3 y | 3-year | at high | +47.7% | at high | -258.0% |
| 5 y | 5-year | +205.9% | +47.7% | at high | -258.0% |
| alltime | all time | -141.7% | +355.8% | -34.9% | -346.0% |
Adamis Pharmaceuticals ROE History
| Date | Annual | Quarterly |
|---|---|---|
| Jun 2023 | - | 518.62%(-163.3%) |
| Mar 2023 | - | -819.27%(+214.8%) |
| Dec 2022 | -211.20%(-32.3%) | -260.29%(+40.5%) |
| Sep 2022 | - | -185.31%(+20.8%) |
| Jun 2022 | - | -153.44%(+34.0%) |
| Mar 2022 | - | -114.53%(-17.2%) |
| Dec 2021 | -311.97%(+15.3%) | -138.27%(-15.8%) |
| Sep 2021 | - | -164.18%(-5.1%) |
| Jun 2021 | - | -172.92%(-14.4%) |
| Mar 2021 | - | -201.95%(-1.7%) |
| Dec 2020 | -270.65%(+292.0%) | -205.40%(+82.1%) |
| Sep 2020 | - | -112.79%(+18.7%) |
| Jun 2020 | - | -95.02%(+32.3%) |
| Mar 2020 | - | -71.82%(+1.1%) |
| Dec 2019 | -69.05%(-23.7%) | -71.06%(-14.8%) |
| Sep 2019 | - | -83.41%(-11.4%) |
| Jun 2019 | - | -94.12%(-5.1%) |
| Mar 2019 | - | -99.13%(+3.1%) |
| Dec 2018 | -90.46%(+14.8%) | -96.12%(+13.6%) |
| Sep 2018 | - | -84.60%(-6.1%) |
| Jun 2018 | - | -90.09%(+14.3%) |
| Mar 2018 | - | -78.82%(+2.2%) |
| Dec 2017 | -78.79%(-29.9%) | -77.13%(+27.9%) |
| Sep 2017 | - | -60.30%(-20.0%) |
| Jun 2017 | - | -75.39%(-24.1%) |
| Mar 2017 | - | -99.32%(-15.1%) |
| Dec 2016 | -112.37%(-22.1%) | -116.97%(-26.8%) |
| Sep 2016 | - | -159.69%(+1.7%) |
| Jun 2016 | - | -156.95%(+17.3%) |
| Mar 2016 | - | -133.76%(+32.1%) |
| Dec 2015 | -144.25%(+67.9%) | -101.23%(+13.1%) |
| Sep 2015 | - | -89.49%(+2.0%) |
| Jun 2015 | - | -87.72%(+13.0%) |
| Mar 2015 | - | -77.64%(-48.9%) |
| Dec 2014 | -85.90%(-58.6%) | - |
| Sep 2014 | - | -151.87%(-33.0%) |
| Jun 2014 | - | -226.80%(-55.2%) |
| Mar 2014 | -207.53%(-224.8%) | -506.61%(-163.6%) |
| Dec 2013 | - | 796.52%(+642.9%) |
| Sep 2013 | - | 107.22%(-14.3%) |
| Jun 2013 | - | 125.12%(-26.6%) |
| Mar 2013 | 166.24%(-7.9%) | 170.36%(-3.7%) |
| Dec 2012 | - | 176.97%(+9.4%) |
| Sep 2012 | - | 161.72%(-29.1%) |
| Jun 2012 | - | 228.03%(-4.8%) |
| Mar 2012 | 180.47%(-64.3%) | 239.64%(-15.4%) |
| Dec 2011 | - | 283.31%(-50.8%) |
| Sep 2011 | - | 576.23%(+48.4%) |
| Jun 2011 | - | 388.40%(+50.1%) |
| Mar 2011 | 505.89%(+222.4%) | 258.69%(-14.6%) |
| Dec 2010 | - | 302.74%(+53.2%) |
| Sep 2010 | - | 197.64%(+0.8%) |
| Jun 2010 | - | 196.04%(-11.3%) |
| Mar 2010 | 156.93% | 221.08%(+101.3%) |
| Dec 2009 | - | 109.82%(-0.3%) |
| Sep 2009 | - | 110.13%(-30.4%) |
| Date | Annual | Quarterly |
|---|---|---|
| Jun 2009 | - | 158.34%(-48.4%) |
| Mar 2009 | - | 307.05%(-153.5%) |
| Dec 2008 | -962.69%(+962.2%) | -573.82%(+152.7%) |
| Sep 2008 | - | -227.12%(+52.3%) |
| Jun 2008 | - | -149.11%(+30.8%) |
| Mar 2008 | - | -114.00%(+25.9%) |
| Dec 2007 | -90.63%(-128.7%) | -90.54%(-115.7%) |
| Sep 2007 | - | 577.92%(-145.3%) |
| Jun 2007 | - | -1275.68%(+338.7%) |
| Mar 2007 | - | -290.78%(+103.4%) |
| Dec 2006 | 315.77%(+308.4%) | -142.98%(-282.4%) |
| Sep 2006 | - | 78.39%(-30.2%) |
| Jun 2006 | - | 112.36%(+166.5%) |
| Mar 2006 | - | 42.16%(-48.4%) |
| Dec 2005 | 77.32%(-81.5%) | 81.64%(-77.3%) |
| Sep 2005 | - | 359.56%(-18.1%) |
| Jun 2005 | - | 438.76%(-2.7%) |
| Mar 2005 | - | 450.85%(-19.2%) |
| Dec 2004 | 417.53%(-238.1%) | 557.76%(+67.7%) |
| Sep 2004 | - | 332.55%(-9.5%) |
| Jun 2004 | - | 367.28%(-136.8%) |
| Mar 2004 | - | -996.91%(+224.1%) |
| Dec 2003 | -302.28%(+188.1%) | -307.55%(+36.1%) |
| Sep 2003 | - | -225.94%(+35.1%) |
| Jun 2003 | - | -167.25%(+18.4%) |
| Mar 2003 | - | -141.25%(+13.3%) |
| Dec 2002 | -104.91%(+4.1%) | -124.65%(-1.1%) |
| Sep 2002 | - | -126.03%(+11.2%) |
| Jun 2002 | - | -113.37%(+13.6%) |
| Mar 2002 | - | -99.83%(+6.5%) |
| Dec 2001 | -100.75%(+52.8%) | -93.72%(+13.3%) |
| Sep 2001 | - | -82.75%(-5.9%) |
| Jun 2001 | - | -87.98%(-5.5%) |
| Mar 2001 | - | -93.13%(+17.1%) |
| Dec 2000 | -65.94%(+6.5%) | -79.56%(+12.0%) |
| Sep 2000 | - | -71.02%(+11.7%) |
| Jun 2000 | - | -63.56%(+2.8%) |
| Mar 2000 | - | -61.83%(-8.4%) |
| Dec 1999 | -61.93%(+49.7%) | -67.51%(+6.7%) |
| Sep 1999 | - | -63.29%(-0.8%) |
| Jun 1999 | - | -63.83%(+17.1%) |
| Mar 1999 | - | -54.52%(+33.5%) |
| Dec 1998 | -41.38%(-30.3%) | -40.83%(-36.2%) |
| Sep 1998 | - | -64.04%(-0.3%) |
| Jun 1998 | - | -64.26%(-3.1%) |
| Mar 1998 | - | -66.29%(-20.3%) |
| Dec 1997 | -59.40%(-23.1%) | -83.16%(+67.9%) |
| Sep 1997 | - | -49.52%(-27.7%) |
| Jun 1997 | - | -68.46%(-15.0%) |
| Mar 1997 | - | -80.57%(-11.4%) |
| Dec 1996 | -77.27%(+26.4%) | -90.91%(-13.9%) |
| Sep 1996 | - | -105.56%(-35.6%) |
| Jun 1996 | - | -163.79%(+58.9%) |
| Mar 1996 | - | -103.09%(+3.1%) |
| Dec 1995 | -61.11% | -100.00%(+26.9%) |
| Sep 1995 | - | -78.79%(-336.4%) |
| Jun 1995 | - | 33.33% |
FAQ
- What is Adamis Pharmaceuticals annual return on equity?
- What is the all time high annual ROE for Adamis Pharmaceuticals?
- What is Adamis Pharmaceuticals annual ROE year-on-year change?
- What is Adamis Pharmaceuticals quarterly return on equity?
- What is the all time high quarterly ROE for Adamis Pharmaceuticals?
- What is Adamis Pharmaceuticals quarterly ROE year-on-year change?
What is Adamis Pharmaceuticals annual return on equity?
The current annual ROE of ADMP is -211.20%
What is the all time high annual ROE for Adamis Pharmaceuticals?
Adamis Pharmaceuticals all-time high annual return on equity is 505.89%
What is Adamis Pharmaceuticals annual ROE year-on-year change?
Over the past year, ADMP annual return on equity has changed by +100.77% (+32.30%)
What is Adamis Pharmaceuticals quarterly return on equity?
The current quarterly ROE of ADMP is 518.62%
What is the all time high quarterly ROE for Adamis Pharmaceuticals?
Adamis Pharmaceuticals all-time high quarterly return on equity is 796.52%
What is Adamis Pharmaceuticals quarterly ROE year-on-year change?
Over the past year, ADMP quarterly return on equity has changed by +672.06% (+438.00%)